Enanta Pharmaceuticals (ENTA) Cash from Investing Activities Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 373.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 373.33% |
| Dec 31, 2025 | -168.64% |
| Sep 30, 2025 | -87.96% |
| Jun 30, 2025 | -317.38% |
| Mar 31, 2025 | -107.45% |
| Dec 31, 2024 | 625.30% |
| Sep 30, 2024 | 61.14% |
| Jun 30, 2024 | 95.65% |
| Mar 31, 2024 | 25.36% |
| Dec 31, 2023 | -139.07% |
| Sep 30, 2023 | -58.07% |
| Jun 30, 2023 | -998.57% |
| Mar 31, 2023 | 233.40% |
| Dec 31, 2022 | -26.22% |
| Sep 30, 2022 | -61.16% |
| Jun 30, 2022 | 137.11% |
| Mar 31, 2022 | -237.70% |
| Dec 31, 2021 | 360.83% |
| Sep 30, 2021 | 2,802.68% |
| Jun 30, 2021 | -263.21% |
| Mar 31, 2021 | -8.25% |
| Dec 31, 2020 | 53.11% |
| Sep 30, 2020 | 104.80% |
| Jun 30, 2020 | 280.37% |
| Mar 31, 2020 | 1,998.94% |
| Dec 31, 2019 | -77.73% |
| Sep 30, 2019 | -556.79% |
| Jun 30, 2019 | 52.81% |
| Mar 31, 2019 | -79.53% |
| Dec 31, 2018 | -755.02% |
| Sep 30, 2018 | 46.65% |
| Jun 30, 2018 | -510.84% |
| Mar 31, 2018 | 257.53% |
| Dec 31, 2017 | -383.01% |
| Sep 30, 2017 | -142.41% |
| Jun 30, 2017 | 124.37% |
| Mar 31, 2017 | 495.19% |
| Dec 31, 2016 | 115.36% |
| Sep 30, 2016 | -250.00% |
| Jun 30, 2016 | -484.48% |
| Mar 31, 2016 | 99.57% |
| Dec 31, 2015 | -180.15% |
| Sep 30, 2015 | -55.52% |
| Jun 30, 2015 | 129.93% |
| Mar 31, 2015 | -723.17% |
| Dec 31, 2014 | 420.90% |
| Sep 30, 2014 | 220.62% |
| Jun 30, 2014 | 43.36% |
| Mar 31, 2014 | 208.77% |
| Dec 31, 2013 | -46.02% |
| Sep 30, 2013 | -182.64% |
| Jun 30, 2013 | -274.14% |